These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5546144)

  • 1. Tentative guidelines referring to inoculation of homologous cancer extracts in man.
    Gross L
    Int J Cancer; 1971 Jan; 7(1):182-5. PubMed ID: 5546144
    [No Abstract]   [Full Text] [Related]  

  • 2. Transmission of cancer in man. Tentative guidelines referring to the possible effects of inoculation of homologous cancer extracts in man.
    Gross L
    Cancer; 1971 Sep; 28(3):785-8. PubMed ID: 4938248
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of cancer in transplantation patients.
    Penn I
    Adv Surg; 1978; 12():155-91. PubMed ID: 367121
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppression and cancer.
    Myking A
    Lancet; 1969 Apr; 1(7597):731. PubMed ID: 4182679
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppression and cancer.
    Penn I; Starzl TE
    Transplant Proc; 1973 Mar; 5(1):943-7. PubMed ID: 4735211
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic rejection of human cancer transplanted with a renal allograft.
    Wilson RE; Hager EB; Hampers CL; Corson JM; Merrill JP; Murray JE
    N Engl J Med; 1968 Feb; 278(9):479-83. PubMed ID: 4866045
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppression and cancer.
    Lancet; 1969 Mar; 1(7593):505-6. PubMed ID: 4179577
    [No Abstract]   [Full Text] [Related]  

  • 8. CADAVERIC RENAL HOMOTRANSPLANTATION WITH INADVERTENT TRANSPLANTATION OF CARCINOMA.
    MARTIN DC; RUBINI M; ROSEN VJ
    JAMA; 1965 May; 192():752-4. PubMed ID: 14285706
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunology in neoplasia relating to diagnosis, therapy and transplantation. Immunosuppression and oncogenesis.
    Cerilli J; Hattan D
    Am J Clin Pathol; 1974 Aug; 62(2):218-23. PubMed ID: 4602088
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemical immunosuppression and human cancer.
    Penn I
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1474-80. PubMed ID: 4608289
    [No Abstract]   [Full Text] [Related]  

  • 11. Iatrogenic modification of tissue responses to infectious agents in the central nervous system.
    Bailey OT; Wolf A; Schneck SA; Rorke LB
    Res Publ Assoc Res Nerv Ment Dis; 1968; 44():445-62. PubMed ID: 4307813
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of immunosuppression for the origin and growth of malignant tumors].
    Reis HE
    Dtsch Med Wochenschr; 1971 Jan; 96(4):170-4. PubMed ID: 4992740
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignancies in recipients of organ transplants.
    Penn I
    Johns Hopkins Med J Suppl; 1974; 3():211-21. PubMed ID: 4608179
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunity to malignant disease in man.
    Fairley GH
    Minerva Pediatr; 1971 Jan; 23(4):151-5. PubMed ID: 5548899
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunology of tumors].
    Surján L
    Orv Hetil; 1969 Aug; 110(31):1777-82. PubMed ID: 4898067
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppression and malignant neoplasms.
    Starzl TE; Penn I; Halgrimson CG
    N Engl J Med; 1970 Oct; 283(17):934. PubMed ID: 4917727
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor-specific immune mechanisms.
    Smith RT
    N Engl J Med; 1968 Jun; 278(24):1326-31 concl. PubMed ID: 4869875
    [No Abstract]   [Full Text] [Related]  

  • 18. Iatrogenic conditions.
    Stollery N
    Practitioner; 2007 Nov; 251(1700):68, 70-1, 73-5. PubMed ID: 18087988
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppression and malignant neoplasms.
    Simmons RL; Najarian JS
    N Engl J Med; 1970 Oct; 283(17):934-5. PubMed ID: 4917728
    [No Abstract]   [Full Text] [Related]  

  • 20. Iatrogenic Kaposi's sarcoma following immunosuppressive therapy for systemic lupus erythematosus.
    el Maghraoui A; Sekkach Y; Qacif H; Abouzahir A; Ghafir D; Ohayon V; Archane MI
    Clin Exp Rheumatol; 2003; 21(5):674. PubMed ID: 14611125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.